Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:FUJHYOTCMKTS:MZDAYOTCMKTS:RNLSYOTCMKTS:SGIOY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFUJHYSubaru$8.63-4.1%$8.87$7.32▼$11.00$12.65B0.44253,533 shs111,645 shsMZDAYMazda Motor$2.85-3.6%$2.95$2.44▼$5.08$3.59B0.65180,561 shs247,230 shsRNLSYRenault$9.74-1.9%$10.34$7.82▼$11.31$14.40B1.4429,683 shs17,524 shsSGIOYShionogi & Co., Ltd.$8.39-0.1%$8.02$6.22▼$8.72$14.27B0.19116,318 shs65,004 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFUJHYSubaru-2.17%-1.16%-1.96%-1.85%-18.77%MZDAYMazda Motor-2.64%-5.45%-2.16%-11.41%-41.58%RNLSYRenault-1.15%-3.99%-8.63%-4.36%-12.95%SGIOYShionogi & Co., Ltd.+1.20%+2.82%-1.75%+9.38%-27.02%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFUJHYSubaru4.6615 of 5 stars0.05.02.50.03.00.05.0MZDAYMazda MotorN/AN/AN/AN/AN/AN/AN/AN/ARNLSYRenaultN/AN/AN/AN/AN/AN/AN/AN/ASGIOYShionogi & Co., Ltd.2.0847 of 5 stars0.05.01.70.02.80.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFUJHYSubaru 1.00SellN/AN/AMZDAYMazda Motor 1.50ReduceN/AN/ARNLSYRenault 2.00HoldN/AN/ASGIOYShionogi & Co., Ltd. 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest MZDAY, RNLSY, SGIOY, and FUJHY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/25/2025RNLSYRenaultDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold4/14/2025FUJHYSubaruSanford C. BernsteinSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong Sell4/14/2025MZDAYMazda MotorSanford C. BernsteinSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong Sell4/2/2025MZDAYMazda MotorDaiwa AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold(Data available from 6/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFUJHYSubaru$32.58B0.39$2.71 per share3.19$12.45 per share0.69MZDAYMazda Motor$33.44B0.11$1.35 per share2.10$9.49 per share0.30RNLSYRenault$60.85B0.24$3.72 per share2.62N/A∞SGIOYShionogi & Co., Ltd.$3.01B4.74$0.81 per share10.34$5.29 per share1.59Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFUJHYSubaru$2.66B$1.514.794.380.258.50%15.26%8.18%8/4/2025 (Estimated)MZDAYMazda Motor$1.43B$0.584.124.18N/A2.66%8.67%3.98%8/6/2025 (Estimated)RNLSYRenault$2.38BN/A0.003.44N/AN/AN/AN/A7/31/2025 (Estimated)SGIOYShionogi & Co., Ltd.$1.12BN/A13.9312.912.3735.53%12.02%10.64%7/28/2025 (Estimated)Latest MZDAY, RNLSY, SGIOY, and FUJHY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q4 2025FUJHYSubaru$0.15$0.10-$0.05$0.10$1,289.35 billion$7.77 billion5/12/2025Q4 2025MZDAYMazda Motor$0.19$0.27+$0.08$0.12$1,304.72 billion$8.72 billion5/12/2025Q4 2025SGIOYShionogi & Co., Ltd.$0.1654$0.14-$0.0254$0.14$824.23 million$721.77 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFUJHYSubaru$0.091.04%N/A5.96%N/AMZDAYMazda Motor$0.051.76%N/A8.62%N/ARNLSYRenault$0.292.98%N/AN/AN/ASGIOYShionogi & Co., Ltd.$0.111.31%N/AN/AN/ALatest MZDAY, RNLSY, SGIOY, and FUJHY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/1/2025RNLSYRenault$0.33093.11%5/7/20255/8/20255/27/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFUJHYSubaru0.132.632.08MZDAYMazda Motor0.301.560.98RNLSYRenaultN/A1.030.97SGIOYShionogi & Co., Ltd.0.017.647.01Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFUJHYSubaru0.01%MZDAYMazda MotorN/ARNLSYRenaultN/ASGIOYShionogi & Co., Ltd.1.92%Insider OwnershipCompanyInsider OwnershipFUJHYSubaruN/AMZDAYMazda MotorN/ARNLSYRenaultN/ASGIOYShionogi & Co., Ltd.N/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFUJHYSubaru17,3471.47 billionN/ANot OptionableMZDAYMazda Motor48,6851.26 billionN/ANot OptionableRNLSYRenault106,0001.48 billionN/ANot OptionableSGIOYShionogi & Co., Ltd.5,6901.70 billionN/ANot OptionableMZDAY, RNLSY, SGIOY, and FUJHY HeadlinesRecent News About These CompaniesShionogi & Co., Ltd. (OTCMKTS:SGIOY) Stock Price Down 1.1% - Here's What HappenedJune 4 at 1:31 AM | marketbeat.comShionogi’s Naldemedine Gains Approval in China for Opioid-Induced ConstipationMay 29, 2025 | tipranks.comShionogi Amends Tender Offer for Torii Pharmaceutical SharesMay 28, 2025 | tipranks.comShionogi Proposes Governance Structure Overhaul to Enhance Strategic OversightMay 16, 2025 | tipranks.comShionogi & Co., Ltd. (OTCMKTS:SGIOY) Releases Quarterly Earnings ResultsMay 15, 2025 | marketbeat.comShionogi & Co., Ltd. (OTCMKTS:SGIOY) Stock Price Down 5.1% - Here's WhyMay 15, 2025 | marketbeat.comShionogi & Co. Reports Fiscal Year 2024 Financial Results with Positive OutlookMay 12, 2025 | tipranks.comJapanese drugmaker Shionogi to acquire JT's pharma units in $1.1bn dealMay 7, 2025 | asia.nikkei.comShionogi Expands Pharmaceutical Capabilities with Strategic AcquisitionsMay 7, 2025 | tipranks.comJapan's drugmaker Shionogi to acquire JT's pharma units in $1bn dealMay 7, 2025 | asia.nikkei.comShionogi Falls on Report of $1 Billion Offer to Buy Torii PharmaMay 7, 2025 | bloomberg.comShionogi’s Ensitrelvir Shows Promise in COVID-19 PreventionMarch 12, 2025 | tipranks.comShionogi targets JPY550B revenue through QOL focus and global expansionFebruary 1, 2025 | msn.comShionogi & Co., Ltd. (SGIOY) Q3 2024 Earnings Call TranscriptJanuary 31, 2025 | seekingalpha.comShionogi's RSV antiviral reduces viral load in phase 2 trial of adultsJanuary 30, 2025 | fiercebiotech.comShionogi & Co. (SGIOY) Upgraded to Buy: What Does It Mean for the Stock?January 27, 2025 | msn.comUS HHS awards Shionogi $375M to develop COVID-19 PrEP therapyJanuary 18, 2025 | bioworld.comShionogi awarded $375m from HHS for preventative Covid-19 injectableJanuary 17, 2025 | finance.yahoo.comShionogi Receives Award Through BARDA's Rapid Response Partnership Vehicle to Advance Long-Acting Formulation of S-892216, an Antiviral for COVID-19 Pre-Exposure Prophylaxis in ...January 16, 2025 | businesswire.comCoronavirus Disease 2019 (SARS-CoV-2) vaccine by Shionogi for Coronavirus Disease 2019 (COVID-19): Likelihood of ApprovalJanuary 5, 2025 | pharmaceutical-technology.comInsomnia drug launched by Nxera Pharma and Shionogi & CoJanuary 3, 2025 | cambridgeindependent.co.ukNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMZDAY, RNLSY, SGIOY, and FUJHY Company DescriptionsSubaru OTCMKTS:FUJHY$8.63 -0.37 (-4.11%) As of 03:59 PM EasternSubaru Corporation manufactures and sells automobiles and aerospace products in Japan, rest of Asia, North America, Europe, and internationally. It operates through three segments: Automotive, Aerospace, and Others. The company manufactures, sells, and repairs passenger cars and their components, aircrafts, aerospace-related machinery, and related components; and rents and manages real estate properties. It is also involved in the shipping, land freight, and warehousing of vehicles; leasing and rental of vehicles; credit and financing of vehicles; inspection, service, and maintenance of aircrafts; and IT system development and operation services. The company was formerly known as Fuji Heavy Industries Ltd. and changed its name to Subaru Corporation in April 2017. The company was founded in 1917 and is headquartered in Tokyo, Japan.Mazda Motor OTCMKTS:MZDAY$2.85 -0.11 (-3.56%) As of 03:55 PM EasternMazda Motor Corporation engages in the manufacture and sale of passenger cars and commercial vehicles in Japan, China, North America, Europe, and internationally. The company was formerly known as Toyo Kogyo Co., Ltd. and changed its name to Mazda Motor Corporation in May 1984. Mazda Motor Corporation was incorporated in 1920 and is headquartered in Hiroshima, Japan.Renault OTCMKTS:RNLSY$9.74 -0.19 (-1.88%) As of 03:50 PM EasternRenault SA engages in the design, manufacture, sale, repair, maintenance, and leasing of motor vehicles in Europe, Eurasia, Africa, the Middle East, the Asia Pacific, and the Americas. It also engages in the design and production of parts and equipment used for manufacturing and operation vehicles. The company operates through Automotive, Sale Financing, and Mobility Services segments. Its Automotive segment produces, sells, and distributes passenger cars and light commercial vehicles; and invests in automotive-sector associates and joint ventures primarily in Nissan. The company's Sale Financing segment offers sale financing, leasing, maintenance, and services contract under the Mobilize Financial Services brand. Its Mobility Services segment provides mobility and energy solutions for electric vehicle users under the Mobilize brand. In addition, it is also involved in the design, manufacture, and sale of passenger cars and light commercial vehicles under the Renault, Dacia, Alpine, and Mobilize brands. Further, the company offers used vehicles and spare parts; and engages in business-to-business powertrain activities, and research and advanced engineering activities. Renault SA was founded in 1898 and is based in Boulogne-Billancourt, France.Shionogi & Co., Ltd. OTCMKTS:SGIOY$8.39 -0.01 (-0.12%) As of 03:58 PM EasternShionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug. It also develops S-872600 an influenza nasal vaccine; S-875670 anCOVID-19 nasal vaccine; S-540956 a nucleic acid adjuvant; S-554110 a nontuberculous mycobacterial infection; S-337395 for RSV infections; S-892216 for COVID-19 therapeutics; Olorofim for invasive aspergillosis; cefiderocol for aerobic gram-negative bacterial infections and infectious diseases; S-268019 a COVID-19 prophylactic vaccine; S-268019 a prophylactic vaccine for COVID-19; ensitrelvir for COVID-19 treatment and prevention; baloxavir for influenza virus infection; S-365598 for HIV infection; and S-555739 for suppressing aggravation of COVID-19. In addition, the company develops S-540956 for nucleic acid adjuvant; S-109802 for post-stroke spasticity; S-151128 for chronic pain; S-588210 and S-531011 for solid tumor; S-309309 for obesity; BPN14770 for Alzheimer's disease and fragile X syndrome; S-588410 for bladder cancer; S-488210 for head and neck squamous cell carcinoma; S-005151 for Acute ischemic stroke and epidermolysis bullosa; Rizmoic for opioid-induced constipation; ADR-001 for decompensated liver cirrhosis; S-222611 for malignant tumor; S-812217 for depression; GRT7039 for pain associated with osteoarthritis of the knee; SDT-001 for inattentive ADHD; S-588410 for esophageal cancer; SR-0379 for cutaneous ulcer; and S-723595 for type 2 diabetes. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio? Is Meta Plotting a Stablecoin Comeback Years After Libra's Flop? NVIDIA Regains Top Spot; FOMO Is Why It Will Continue to Rise Robinhood Stock Keeps Giving Investors Reasons To Buy Hims & Hers Stock: Buy the Dip or Wait It Out? Boeing: Analyst Upgrades & Order Boom Signal Clearer Skies CrowdStrike Stock Dips on Guidance Miss: It May Rebound Fast A New All-Time High Is Coming Soon for Credo Technology Group Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
